A randomised controlled trial comparing the efficacy of withdrawing alpha blocker following initial combination therapy with dual 5 alpha reductase inhibitor (5-ARI) dutasteride compared to continuation of combination therapy in the management of benign prostatic hyperlasia - Krishna Kumar (Universiti Kebangsaan Malaysia, 2012)